209 related articles for article (PubMed ID: 23078262)
21. Evidence for colorectal cancer screening.
Bretthauer M
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
[TBL] [Abstract][Full Text] [Related]
22. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
23. Population-based programs for increasing colorectal cancer screening in the United States.
Verma M; Sarfaty M; Brooks D; Wender RC
CA Cancer J Clin; 2015; 65(6):497-510. PubMed ID: 26331705
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer screening among Latinos from U.S. cities along the Texas-Mexico border.
Fernandez ME; Wippold R; Torres-Vigil I; Byrd T; Freeberg D; Bains Y; Guajardo J; Coughlin SS; Vernon SW
Cancer Causes Control; 2008 Mar; 19(2):195-206. PubMed ID: 18038186
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer screening.
Bretthauer M
J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.
Dougherty MK; Brenner AT; Crockett SD; Gupta S; Wheeler SB; Coker-Schwimmer M; Cubillos L; Malo T; Reuland DS
JAMA Intern Med; 2018 Dec; 178(12):1645-1658. PubMed ID: 30326005
[TBL] [Abstract][Full Text] [Related]
27. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
[TBL] [Abstract][Full Text] [Related]
28. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
29. Family Physicians' Knowledge, Attitudes, and Practices Toward Colorectal Cancer Screening.
Şahin MK; Aker S
J Cancer Educ; 2017 Dec; 32(4):908-913. PubMed ID: 27193411
[TBL] [Abstract][Full Text] [Related]
30. Cost-Effectiveness of Community Interventions for Colorectal Cancer Screening: Low-Income Hispanic Population.
Lairson DR; Kim J; Byrd T; Salaiz R; Shokar NK
Health Promot Pract; 2018 Nov; 19(6):863-872. PubMed ID: 29290126
[TBL] [Abstract][Full Text] [Related]
31. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
Stock C; Ihle P; Schubert I; Brenner H
Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
[TBL] [Abstract][Full Text] [Related]
32. Improvement in Hispanics' CRC Knowledge and Awareness using the Inflatable Caribe Colon.
Portilla-Skerrett GM; Díaz-Algorri Y; Soto-Salgado M; Cruz-Correa M
P R Health Sci J; 2019 Sep; 38(3):176-180. PubMed ID: 31536631
[TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
34. Testing a culturally appropriate, theory-based intervention to improve colorectal cancer screening among Native Hawaiians.
Braun KL; Fong M; Kaanoi ME; Kamaka ML; Gotay CC
Prev Med; 2005 Jun; 40(6):619-27. PubMed ID: 15850857
[TBL] [Abstract][Full Text] [Related]
35. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
[TBL] [Abstract][Full Text] [Related]
36. The impact of stratifying by family history in colorectal cancer screening programs.
Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
[TBL] [Abstract][Full Text] [Related]
37. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
38. Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada.
Vahabi M; Lofters A; Wong JP; Ellison L; Graves E; Damba C; Glazier RH
Cancer Med; 2019 Nov; 8(16):7108-7122. PubMed ID: 31568705
[TBL] [Abstract][Full Text] [Related]
39. Qualitative Analysis of Colorectal Cancer Screening for African American and Hispanic Populations in Nebraska: an Application of the PRECEDE Framework.
Napit K; Ratnapradipa KL; King KM; Ramos AK; Luma LBL; Dinkel D; Robinson T; Schabloske L; Tchouankam T; Watanabe-Galloway S
J Cancer Educ; 2023 Oct; 38(5):1767-1776. PubMed ID: 37466902
[TBL] [Abstract][Full Text] [Related]
40. [Screening for colorectal cancer using immunological fecal occult blood test in inpatients].
Kawabata H; Inoue N; Kawakatsu Y; Okazaki Y; Hitomi M; Miyata M; Motoi S
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(4):377-384. PubMed ID: 29643290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
